IP Library › Granted Patent US 12,630,683
Granted Patent B2
US 12,630,683 · App. 18/221,595 · Granted May 19, 2026

Medical device with tunable hydrophobicity and method of manufacture

Inventors: Yen-Hao Hsu (Shrewsbury, MA); Joseph Thomas Delaney, Jr. (Minneapolis, MN); Paul Vincent Grosso (Maple Grove, MN); Patrick Willoughby (Shoreview, MN)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
C08J7/12A61L31/10B32B27/40B32B2307/728B32B2307/73C08J2375/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,630,683
App. No.
18/221,595
Granted
May 19, 2026
Kind
B2
Abstract

A medical device include a polyurethane layer and a hydro-specific layer that is covalently bonded to the polyurethane layer. The polyurethane layer may include a plurality of monomer residues, at least some of which include pendent alkene groups. The hydro-specific layer may be a hydrophilic layer or a hydrophobic layer depending on the specific molecules used to form the hydro-specific layer. As an example, the hydro-specific layer may be covalently bonded to the polyurethane layer via a thiol-ene or alkene hydrothiolation reaction between the plurality of pendent alkene groups and a plurality of thiol-terminated hydro-specific molecules forming the hydro-specific layer.

Claims (30)

1 . A medical device, comprising:

a polyurethane layer comprising a plurality of monomer residues;

wherein at least some of the plurality of monomer residues include a chain extender molecule with a pendent alkene group;

wherein the chain extender molecule comprises a residue of one or more of:

a hydro-specific layer covalently bonded to the polyurethane layer via a thiol-ene reaction between the plurality of pendent alkene groups and a plurality of thiol-terminated hydro-specific molecules forming the hydro-specific layer.

2 . The medical device of claim 1 , wherein the hydro-specific layer comprises a hydrophilic layer.

3 . The medical device of claim 2 , wherein the hydrophilic layer is formed from a plurality of thiol-terminated hydro-specific molecules comprising one or more of:

4 . The medical device of claim 1 , wherein the hydro-specific layer comprises a hydrophobic layer.

5 . The medical device of claim 4 , wherein the hydrophobic layer is formed from a plurality of thiol-terminated hydro-specific molecules comprising one or more of:

6 . The medical device of claim 1 , comprising a first region and a second region, with the polyurethane layer extending through the first region and the second region, and the hydro-specific layer comprises a first hydro-specific layer within the first region covalently bonded to the polyurethane layer and a second hydro-specific layer, different from the first hydro-specific layer, disposed within the second region covalently bonded to the polyurethane layer.

7 . The medical device of claim 6 , wherein the first hydro-specific layer comprises a hydrophilic layer and the second hydro-specific layer comprises a hydrophobic layer.

8 . A medical device having a first region and a second region, the medical device comprising:

a polyurethane layer comprising a plurality of monomer residues, the polyurethane layer extending through the first region and the second region;

wherein at least some of the plurality of monomer residues include a chain extender molecule with a pendent alkene group;

wherein the chain extender molecule comprises a residue of one or more of:

a first hydro-specific layer covalently bonded to the polyurethane layer within the first region; and

a second hydro-specific layer covalently bonded to the polyurethane layer within the second region.

9 . The medical device of claim 8 , wherein the first hydro-specific layer provides a first contact angle and the second hydro-specific contact angle provides a second contact angle different from the first contact angle.

10 . The medical device of claim 9 , wherein the first hydro-specific layer provides a contact angle of less than or equal to 90 degrees.

11 . The medical device of claim 9 , wherein the second hydro-specific layer provides a contact angle of greater than 90 degrees.

12 . The medical device of claim 8 , wherein the first hydro-specific layer is covalently bonded to the polyurethane layer via a thiol-ene reaction between the plurality of pendent alkene groups and a plurality of thiol-terminated hydro-specific molecules forming the first hydro-specific layer.

13 . The medical device of claim 8 , wherein the second hydro-specific layer is covalently bonded to the polyurethane layer via a thiol-ene reaction between the plurality of pendent alkene groups and a plurality of thiol-terminated hydro-specific molecules forming the second hydro-specific layer.

14 . A medical device, comprising:

a polyurethane layer formed to include a plurality of pendent functional chemical handles;

wherein the polyurethane layer include a chain extender molecule having the plurality of pendent functional chemical handles;

wherein the chain extender molecule comprises a residue of one or more of:

a hydro-specific layer covalently bonded to the polyurethane layer, the hydro-specific layer including a plurality of hydro-specific molecules covalently bonded to the plurality of pendent functional chemical handles.

15 . The medical device of claim 14 , wherein the plurality of pendent functional chemical handles comprise a plurality of pendant alkene groups.

16 . The medical device of claim 15 , wherein the plurality of hydro-specific molecules comprise thiol-terminated hydro-specific molecules.

17 . The medical device of claim 16 , wherein the hydro-specific layer is covalently bonded to the polyurethane layer via an alkene hydrothiolation reaction between the plurality of pendant alkene groups and the thiol-terminated hydro-specific molecules.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2023
From: HSU, YEN-HAO; DELANEY, JOSEPH THOMAS, JR.; GROSSO, PAUL VINCENT; WILLOUGHBY, PATRICK
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 064245/0057 →
Continuity (2)
Provisional Application 63389103 · Jul 14, 2022
Related Publication 20240043643A1 · Feb 8, 2024
References Cited (12)
US 20160296323A1 · Wulfman et al. · 2016 [cited by applicant]
US 20190218334A1 · Delaney, Jr. et al. · 2019 [cited by applicant]
US 20210260256A1 · Boodagh et al. · 2021 [cited by applicant]
US 20230257507A1 · Shin · 2023 [cited by examiner]
WO 2020212978A1 · 2020 [cited by applicant]
WO 2022010288A1 · 2022 [cited by applicant]
Shu et al., “Attachment and Spreading of Fibrolasts on an RGD Peptide-Modified Injectable Hyaluronan Hydrogel,” © 2003 Wiley Periodicals, Inc. J Biomed Mater Res vol. 68A, pp. 365-375, 2004. [cited by applicant]
Zander et al., “Antimicrobial and Antifouling Strategies for Polymeric Medical Devices,” ACS Macro Letters, vol. 7 pp. 16-25, 2018. [cited by applicant]
Zander et al., “Post-Fabrication QAC-Functionalized Thermoplastic Polyurethane for Contact-Killing Catheter Applications,” Biomaterials, vol. 178, pp. 339-350, 2018. [cited by applicant]
International Search Report and Written Opinion dated Nov. 10, 2023 for International Application No. PCT/US2023/027651. [cited by applicant]
Alibeik et al., “The effect of thiolation on the mechanical and protein adsorption properties of plyurethanes,” European Polymer Journal, 43, pp. 1415-1427, 2007. [cited by applicant]
Hoyle et al., “Thiol-Ene Click Chemistry,” Angew. Chem. Int. Ed., 49, pp. 1540-1573, 2010. [cited by applicant]